A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val66Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects.
Poor inhibitory processing of negative emotional content is central to many psychiatric disorders, including depression and anxiety. Moreover, increasing evidence suggests that core aspects of emotion-inhibitory processing are largely inherited and as such may represent a key intermediate or risk-related phenotype for common affective diseases (e.g., unipolar depressive, anxiety disorders). The current study employed a candidate-gene approach in order to most effectively examine this complex behavioral phenotype. We examined the novel interaction between BDNF (Val66Met) and TPH2 (rs4570625) polymorphisms and their influence on behavioral inhibition of negative emotion in two independent investigations of healthy adults. BDNF Met carriers consistently report greater symptoms of affective disease and display corresponding behavioral rigidity, while TPH2 T carriers display poor inhibitory processing. These genotypes are traditionally perceived as 'risk' genotypes when compared to their respective major Val and G homozygous genotypes, but evidence is mixed. Recent studies in humans and mutant mouse models suggest biological epistasis between BDNF and genes involved in serotonin regulation. Moreover, polymorphisms in the TPH2 gene may have greater influence on serotonergic function than other more commonly studied polymorphisms (e.g., 5-HTTLPR). We observed consistent evidence across two different emotion-inhibition paradigms, one with high internal validity (Study 1, n = 119) and one with high ecological validity (Study 2, n = 115) that the combination of Val/Val and G/G genotypes was clearly associated with impaired inhibition of negative emotional content. This was followed by individuals carrying the BDNF-Met allele (including Met/Val and Met/Met) when combined with the TPH2-T allele (including T/G and T/T combinations). The consistency of these results across tasks and studies suggests that these two groups may be particularly vulnerable to the most common psychiatric disorders and should be targets for future clinical investigation.
Department of Psychological Sciences, Kent State University, Kent, OH, 44242, United States of America.
Maeson S
MS
Latsko
Department of Psychological Sciences, Kent State University, Kent, OH, 44242, United States of America.
T Lee
TL
Gilman
Department of Psychological Sciences, Kent State University, Kent, OH, 44242, United States of America.
Lindsey M
LM
Matt
Department of Psychological Sciences, Kent State University, Kent, OH, 44242, United States of America.
K Maria
KM
Nylocks
Department of Psychological Sciences, Kent State University, Kent, OH, 44242, United States of America.
Karin G
KG
Coifman
Department of Psychological Sciences, Kent State University, Kent, OH, 44242, United States of America.
Aaron M
AM
Jasnow
D000342:Affective Symptoms / Q000235:genetics; D019943:Amino Acid Substitution / Q000235:genetics / Q000502:physiology; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics* / Q000502:physiology; D004644:Emotions; D004843:Epistasis, Genetic / Q000235:genetics; D005260:Female; D056726:Genetic Association Studies; D006801:Humans; D007266:Inhibition, Psychological; D008297:Male; D012150:Polymorphism, Restriction Fragment Length / Q000235:genetics; D020641:Polymorphism, Single Nucleotide / Q000235:genetics* / Q000502:physiology; D012307:Risk Factors; D057190:Stroop Test; D014365:Tryptophan Hydroxylase / Q000235:genetics* / Q000502:physiology; D055815:Young Adult
D019208:Brain-Derived Neurotrophic Factor; C579455:BDNF protein, human; C494784:TPH2 protein, human; D014365:Tryptophan Hydroxylase
J Neurosci Res. 2000 Aug 1;61(3):295-301
10900076
Nature. 2002 Mar 28;416(6879):396-400
11919622
Science. 2003 Jan 3;299(5603):76
12511643
Cell. 2003 Jan 24;112(2):257-69
12553913
Behav Genet. 2003 Jan;33(1):73-8
12645824
Am J Psychiatry. 2003 Apr;160(4):636-45
12668349
J Neurosci. 2003 Jul 30;23(17):6690-4
12890761
Emotion. 2002 Jun;2(2):135-46
12899187
J Biol Chem. 1956 Mar;219(1):335-44
13295286
Child Dev. 1992 Dec;63(6):1437-55
1446561
Biochem Pharmacol. 2003 Nov 1;66(9):1673-80
14563478
Nat Rev Neurosci. 2003 Dec;4(12):1002-12
14618156
Genes Brain Behav. 2003 Dec;2(6):350-64
14653307
Biol Psychiatry. 2004 Mar 15;55(6):612-20
15013830
Mol Psychiatry. 2004 Nov;9(11):1030-6
15124006
Mol Psychiatry. 2004 Nov;9(11):980-1
15263906
J Neurosci. 2004 Nov 10;24(45):10099-102
15537879
J Neurosci Res. 2005 Mar 15;79(6):756-71
15672416
Clin Psychol Rev. 2005 May;25(3):307-39
15792852
Mol Psychiatry. 2005 Sep;10(9):884-8, 805
16044172
Int J Neuropsychopharmacol. 2006 Aug;9(4):437-42
16146581
J Neural Transm (Vienna). 2005 Nov;112(11):1479-85
16245070
Annu Rev Psychol. 2006;57:117-37
16318591
J Abnorm Psychol. 2005 Nov;114(4):627-39
16351385
Biol Psychiatry. 2006 May 1;59(9):812-5
16442082
Behav Res Ther. 2007 Mar;45(3):511-21
16759637
Cereb Cortex. 2007 May;17(5):1160-3
16801378
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):755-80
17029036
Int J Neuropsychopharmacol. 2007 Jun;10(3):401-4
17176491
Int J Neuropsychopharmacol. 2007 Jun;10(3):309-20
17176492
J Cogn Neurosci. 2007 Mar;19(3):401-8
17335389
Neuropsychopharmacology. 2007 Dec;32(12):2552-60
17392738
J Neural Transm (Vienna). 2007;114(8):1065-8
17401528
Biol Psychiatry. 2007 Dec 1;62(11):1288-94
17568567
J Abnorm Psychol. 1991 Nov;100(4):569-82
1757671
Annu Rev Clin Psychol. 2005;1:167-95
17716086
Neuropsychopharmacology. 2008 Jan;33(1):134-40
17851538
J Cogn Neurosci. 2007 Dec;19(12):1923-31
17892388
Hum Genet. 2008 Jan;122(6):645-57
17972101
BMC Bioinformatics. 2007 Nov 02;8:428
17980034
Neuroscience. 2008 Mar 27;152(3):573-84
18295409
Mol Psychiatry. 2008 Jul;13(7):709-16
18347599
J Exp Psychol Gen. 2008 May;137(2):201-25
18473654
Infant Behav Dev. 2009 Jan;32(1):1-9
18995913
Behav Brain Res. 2009 Mar 17;198(2):404-10
19071164
Mol Psychiatry. 2010 Jun;15(6):589-601
19107115
Eur Neuropsychopharmacol. 2009 Apr;19(4):266-82
19181488
Biol Psychiatry. 2009 Sep 1;66(5):477-85
19500776
Neuroscience. 2009 Nov 24;164(1):43-54
19559759
Q J Exp Psychol (Hove). 2010 Jan;63(1):42-9
19691003
Int J Environ Res Public Health. 2009 Jul;6(7):1980-90
19742166
Biol Psychol. 2010 Feb;83(2):93-100
19914329
Science. 2010 Feb 12;327(5967):863-6
20075215
Mol Psychiatry. 2011 Feb;16(2):193-201
20125088
Biol Psychiatry. 2010 Apr 15;67(8):722-9
20172508
Annu Rev Clin Psychol. 2010;6:285-312
20192795
Cogn Emot. 2010 Feb 1;24(2):281-98
20300538
Mol Psychiatry. 2011 May;16(5):516-32
20351714
Am J Psychiatry. 2010 Aug;167(8):949-57
20516156
J Abnorm Psychol. 2010 Aug;119(3):479-90
20677837
Curr Psychiatry Rep. 2010 Dec;12(6):539-46
20848240
Psychol Sci. 2010 Nov;21(11):1678-85
20921572
Mol Psychiatry. 2012 Jan;17(1):36-48
21042317
Behav Res Ther. 2011 Mar;49(3):186-93
21238951
Psychoneuroendocrinology. 2011 Apr;36(3):393-405
21257271
Soc Cogn Affect Neurosci. 2012 Mar;7(3):253-62
21296865
J Abnorm Psychol. 2011 Feb;120(1):187-97
21319930
Cogn Emot. 2011 Apr;25(3):400-12
21432682
Pharmacol Ther. 2011 Jul;131(1):61-79
21447358
Neurobiol Aging. 2011 Dec;32(12):2327.e7-19
21803453
Neuropharmacology. 2012 Jan;62(1):144-54
21945798
Hum Brain Mapp. 2013 Jun;34(6):1344-56
22331598
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5469-74
22431635
Emotion. 2012 Apr;12(2):229-35
22468617
J Abnorm Psychol. 2012 Aug;121(3):570-8
22468767
Neuroscience. 2012 Jul 12;214:59-67
22531372
PLoS One. 2012;7(5):e36721
22693556
Bull Exp Biol Med. 2012 Mar;152(5):606-9
22803145
Mol Psychiatry. 2013 Oct;18(10):1106-18
23007167
Am J Med Genet B Neuropsychiatr Genet. 2013 Jan;162B(1):61-70
23184535
Psychol Sci. 2013 Mar 1;24(3):334-44
23334445
Biol Psychol. 2013 Apr;93(1):65-74
23384513
J Child Adolesc Psychopharmacol. 2013 Mar;23(2):117-22
23510446
Emotion. 2013 Jun;13(3):359-65
23527510
Neuroscience. 2013 Sep 26;249:88-97
23850503
Nat Genet. 2013 Sep;45(9):984-94
23933821
Neuroimage. 2014 Jul 1;94:33-39
24607934
J Abnorm Psychol. 2014 Feb;123(1):35-48
24661157
Behav Brain Res. 2015 Jan 15;277:3-13
24859172
J Abnorm Psychol. 2014 May;123(2):350-61
24886009
Dev Cogn Neurosci. 2015 Feb;11:42-55
25238998
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:31-5
25455586
Neuropsychopharmacology. 2015 Aug;40(9):2269-77
25786582
Neuropsychopharmacology. 2015 Dec;40(13):2929-37
26013962
Eur Arch Psychiatry Clin Neurosci. 2016 Apr;266(3):281-4
26100147
Perspect Psychol Sci. 2010 Jan;5(1):43-57
26162062
Genet Epidemiol. 2016 May;40(4):341-51
27061818
Clin Psychol (New York). 2013 Sep;20(3):258-267
27890972
Behav Res Ther. 1985;23(5):563-9
4051929
Exp Neurol. 1995 Feb;131(2):229-38
7534721
Dev Biol. 1995 Jul;170(1):169-82
7601307
Psychol Rev. 1995 Jan;102(1):68-100
7878163
Arch Gen Psychiatry. 1993 Apr;50(4):295-305
8466391
J Neurosci. 1995 Dec;15(12):7929-39
8613731
Psychol Bull. 1996 Jul;120(1):3-24
8711015
Brain Res. 1996 Feb 26;710(1-2):11-20
8963648